BREAKING NEWS

Pfizer, BioNTech launch COVID-19 vaccine trial in kids under 12

Pfizer Inc and German partner BioNTech SE began testing their COVID-19 vaccine in children under 12, with hopes of expanding vaccination to that age range by early 2022, the US drugmaker said on Thursday.
The first volunteers in the early-stage trial were given their first injections on Wednesday, Pfizer spokesperson Sharon Castillo said.
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use

Read all Tweets >